Ameriprise’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.1B | Buy |
3,733,549
+18,872
| +0.5% | +$5.61M | 0.26% | 86 |
|
|
2025
Q4 | $1.01B | Sell |
3,714,677
-1,098,237
| -23% | -$298M | 0.23% | 87 |
|
|
2025
Q3 | $1.3B | Buy |
4,812,914
+130,848
| +3% | +$35.6M | 0.3% | 63 |
|
|
2025
Q2 | $1.29B | Buy |
4,682,066
+92,925
| +2% | +$25.3M | 0.32% | 59 |
|
|
2025
Q1 | $1.22B | Sell |
4,589,141
-5,223
| -0.1% | -$1.29M | 0.33% | 59 |
|
|
2024
Q4 | $1.07B | Sell |
4,594,364
-197,277
| -4% | -$45.4M | 0.27% | 70 |
|
|
2024
Q3 | $1.06B | Sell |
4,791,641
-491,555
| -9% | -$102M | 0.27% | 72 |
|
|
2024
Q2 | $1.04B | Buy |
5,283,196
+537,758
| +11% | +$111M | 0.28% | 70 |
|
|
2024
Q1 | $1.02B | Buy |
4,745,438
+577,994
| +14% | +$121M | 0.28% | 70 |
|
|
2023
Q4 | $878M | Buy |
4,167,444
+588,387
| +16% | +$126M | 0.26% | 82 |
|
|
2023
Q3 | $717M | Buy |
3,579,057
+125,263
| +4% | +$24.9M | 0.24% | 91 |
|
|
2023
Q2 | $640M | Buy |
3,453,794
+113,922
| +3% | +$21.1M | 0.2% | 106 |
|
|
2023
Q1 | $640M | Sell |
3,339,872
-286,023
| -8% | -$51.7M | 0.21% | 115 |
|
|
2022
Q4 | $610M | Sell |
3,625,895
-13,119
| -0.4% | -$2.28M | 0.21% | 111 |
|
|
2022
Q3 | $645M | Buy |
3,639,014
+587,130
| +19% | +$116M | 0.24% | 98 |
|
|
2022
Q2 | $625M | Buy |
3,051,884
+311,480
| +11% | +$66M | 0.22% | 103 |
|
|
2022
Q1 | $651M | Buy |
2,740,404
+245,427
| +10% | +$57.6M | 0.19% | 113 |
|
|
2021
Q4 | $570M | Buy |
2,494,977
+131,522
| +6% | +$28.9M | 0.16% | 135 |
|
|
2021
Q3 | $457M | Sell |
2,363,455
-529,955
| -18% | -$107M | 0.15% | 154 |
|
|
2021
Q2 | $615M | Sell |
2,893,410
-408,288
| -12% | -$86.2M | 0.19% | 114 |
|
|
2021
Q1 | $674M | Buy |
3,301,698
+417,809
| +14% | +$82.3M | 0.22% | 90 |
|
|
2020
Q4 | $525M | Buy |
2,883,889
+171,452
| +6% | +$29.2M | 0.19% | 114 |
|
|
2020
Q3 | $454M | Sell |
2,712,437
-5,993
| -0.2% | -$1.01M | 0.18% | 113 |
|
|
2020
Q2 | $442M | Buy |
2,718,430
+59,488
| +2% | +$10.7M | 0.19% | 111 |
|
|
2020
Q1 | $460M | Buy |
2,658,942
+305,007
| +13% | +$60.7M | 0.24% | 87 |
|
|
2019
Q4 | $472M | Sell |
2,353,935
-263,304
| -10% | -$54M | 0.2% | 104 |
|
|
2019
Q3 | $553M | Sell |
2,617,239
-314,125
| -11% | -$65.6M | 0.25% | 80 |
|
|
2019
Q2 | $569M | Sell |
2,931,364
-166,250
| -5% | -$30.6M | 0.25% | 81 |
|
|
2019
Q1 | $510M | Buy |
3,097,614
+222,618
| +8% | +$39.4M | 0.23% | 79 |
|
|
2018
Q4 | $541M | Buy |
2,874,996
+413,790
| +17% | +$76.4M | 0.27% | 75 |
|
|
2018
Q3 | $424M | Sell |
2,461,206
-281,973
| -10% | -$47.5M | 0.15% | 154 |
|
|
2018
Q2 | $450M | Buy |
2,743,179
+564,597
| +26% | +$92.2M | 0.2% | 104 |
|
|
2018
Q1 | $352M | Sell |
2,178,582
-178,432
| -8% | -$28.4M | 0.16% | 147 |
|
|
2017
Q4 | $344M | Sell |
2,357,014
-120,116
| -5% | -$17.1M | 0.16% | 143 |
|
|
2017
Q3 | $336M | Sell |
2,477,130
-334,782
| -12% | -$42.3M | 0.16% | 139 |
|
|
2017
Q2 | $352M | Sell |
2,811,912
-387,717
| -12% | -$46.4M | 0.18% | 129 |
|
|
2017
Q1 | $380M | Sell |
3,199,629
-713,572
| -18% | -$85.8M | 0.2% | 113 |
|
|
2016
Q4 | $452M | Sell |
3,913,201
-286,352
| -7% | -$31.9M | 0.25% | 85 |
|
|
2016
Q3 | $439M | Buy |
4,199,553
+290,172
| +7% | +$30.3M | 0.25% | 86 |
|
|
2016
Q2 | $381M | Buy |
3,909,381
+111,901
| +3% | +$10.6M | 0.22% | 97 |
|
|
2016
Q1 | $365M | Buy |
3,797,480
+434,702
| +13% | +$39.5M | 0.22% | 104 |
|
|
2015
Q4 | $305M | Sell |
3,362,778
-2,041
| -0.1% | -$192K | 0.18% | 119 |
|
|
2015
Q3 | $312M | Sell |
3,364,819
-308,412
| -8% | -$29.3M | 0.19% | 105 |
|
|
2015
Q2 | $342M | Buy |
3,673,231
+368,338
| +11% | +$34.4M | 0.19% | 114 |
|
|
2015
Q1 | $313M | Sell |
3,304,893
-580,207
| -15% | -$53.8M | 0.18% | 123 |
|
|
2014
Q4 | $345M | Buy |
3,885,100
+276,431
| +8% | +$23.4M | 0.2% | 122 |
|
|
2014
Q3 | $289M | Buy |
3,608,669
+1,209,241
| +50% | +$91.1M | 0.17% | 141 |
|
|
2014
Q2 | $170M | Sell |
2,399,428
-241,546
| -9% | -$17M | 0.1% | 211 |
|
|
2014
Q1 | $195M | Sell |
2,640,974
-961,157
| -27% | -$72.5M | 0.12% | 191 |
|
|
2013
Q4 | $283M | Buy |
3,602,131
+1,348,374
| +60% | +$106M | 0.17% | 143 |
|
|
2013
Q3 | $166M | Buy |
2,253,757
+743,748
| +49% | +$54.8M | 0.11% | 213 |
|
|
2013
Q2 | $115M | Buy |
+1,510,009
| New | +$99.1M | 0.08% | 281 |
|
Other funds holding CME
VCM
VPM
Ameriprise's CME Position: Q1 2026 in Review
Ameriprise increased its CME Group (CME) stake by 0.51% in Q1 2026, buying an estimated $5.61M and bringing the position to 3,733,549 shares worth $1.1B. The position accounts for 0.26% of the portfolio, ranked #86.
Ameriprise first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.3B in Q3 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Ameriprise held 3,733,549 shares of CME Group worth $1.1B as of Q1 2026.
- Ameriprise bought 18,872 CME Group shares in Q1 2026, an estimated $5.61M.
- CME Group made up 0.26% of Ameriprise's portfolio in Q1 2026, its #86 holding.
- Ameriprise first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's CME Group position peaked at $1.3B in Q3 2025.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.